Ignite Creation Date:
2024-07-17 @ 11:16 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06469138
Status:
COMPLETED
Last Update Posted:
2024-06-21
First Post:
2024-06-17
Brief Title:
A Phase 1 Study to Investigate 14C-bemcentinib Following Single Oral Administration in Healthy Male Subjects
Sponsor:
BerGenBio ASA
Organization:
BerGenBio ASA
Organization Data
Organization:
BerGenBio ASA
Class:
INDUSTRY
Study ID:
BGBC021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BerGenBio ASA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None